International Society for Laboratory Hematology

Home
About ISLH
- Quick Tips
- History
- Board
- Committees
- Guidelines
- Mission
- Bylaws
- Conflict of Interest
- Presidential Update
- Contact
Membership
Conference
Education
Journal
Sponsors
Contact Us

Inventory of Guidelines

ISLH is committed to ensuring an up to date inventory of guidelines that support the Hematology Laboratory community. To this end, below are additional guidelines.

Pre-analytical
Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis	BCSH	2012	View
Strategies for eliciting and synthesizing evidence for guidelines in rare diseases	BMC	2019	View
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum	Anticoagulation Forum	2019	View
Hematopathology
Nucleic acid amplification assays for molecular hematopathology: Approved Guideline – second edition	CLSI (this is now listed as a hematology document)	2012	View
Coagulation
Internal quality control practices in coagulation laboratories: recommendations based on a patterns-of-practice survey	IQMH	2015	View Additional Information
Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH	ISTH	2015	View
Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH	ISTH	2014	View
Validation of hemostasis and coagulation assays: recommendations and guidelines	Independent authors (STH)	2014	View Additional Information
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology	UKHCDO / BCSH	2014	View
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative	NIH	2017	View
Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations	NIH	2017	View
Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL	Blood Transfusion	2017	View
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants	ICSH	2018	View
Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH	ISTH SSC	2018	View
Hemoglobinopathies and other red cell disorders
ICSH recommendations for assessing automated high-performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2	ICSH	2015	View
ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders Supporting information	ICSH	2015	View Additional Information
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes	ICSH	2011	View
Cellular analysis, including peripheral blood, bone marrow and body fluid analysis
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.	WHO	2016	View
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features Supporting information	ICSH	2015	View Additional Information
ICSH guidelines for the standardization of bone marrow immunohistochemistry	ICSH	2015	View
ICSH guidelines for the evaluation of blood cell analyzers including those used for differential leucocyte and reticulocyte counting	ICSH	2014	View
ICSH guidelines for the verification and performance of automated cell counters for body fluids	ICSH	2014	View
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology	CAP	2016	View
Flow Cytometry
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work package 10	ESCCA	2011	View Additional Information
Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group	PBC	2016	View
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders Part 1 – clinical utility Part 2 – reagent selection and assay optimization for high-sensitivity testing Part 3 – data analysis, reporting and case studies Part 4 – assay validation and quality assurance	ICCS/ESCCA	2018	View

The following guidelines are not restricted to laboratory testing:

Guideline for the diagnosis and management of the rare coagulation disorders. A United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology	UKHCDO / BCSH	2014	View
Patient self-testing and self-management oforal anticoagulant with vitamin K antagonists: guidance from the British Committee for Standards in Haematology	BCSH	2014	View
Diagnosis and management of acquired coagulation inhibitors: a guideline form UKHCDO	UKHCDO / BCSH	2013	View
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)	UKHCDO / BCSH	2013	View
Review of the NICE guidelines for multiple myeloma	NCBI	2017	View
WFH Guidelines for the Management of Hemophilia, 2nd edition	WFH	2012	View
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome	McMaster RARE-Bestpractices project group	2018	View
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when	European Myeloma Network	2018	View
EULAR recommendations for the management of antiphospholipid syndrome in adults	EULAR	2019	View
Post-analytical
Recommendations on the Standardization of Critical Results in Hematology – Adult Population	ICSH	2016	View
Guideline Papers	ICSH	2018	View
Guideline Papers	BSH	2016	View

Inventory of Guidelines

Account Login